No Detail Found!

Clinical efficacy and safety of repetitive transcranial magnetic stimulation (RTMS) in combination with antipsychotic medications in patients with schizophrenia

Author(s)
Jiahui Yin Department of General Psychiatry, the Seventh People's Hospital of Wenzhou,,China
Bojian Dai Department of General Psychiatry, the Seventh People's Hospital of Wenzhou,,China
Ruru Chen Department of General Psychiatry, the Seventh People's Hospital of Wenzhou,,China
Lingyi Dai Department of General Psychiatry, the Seventh People's Hospital of Wenzhou,,China
Lixue Qiu Department of Geriatric Psychiatry, the Seventh People's Hospital of Wenzhou,,China
Abstract
The global prevalence of schizophrenia is about 0.40% and in some parts of my country it is 0.54%-0.94%. Its treatment faces many difficulties. Antipsychotic drugs are commonly used treatments, but they have many side effects; repetitive transcranial magnetic stimulation (rTMS), as a non-invasive physical therapy, has a certain effect in improving mental and living abilities. This study used a randomized controlled trial to divide 100 patients into an experimental group (rTMS + drugs) and a control group (drugs only) and evaluated them with multiple scales. The relapse rate during the 24month follow-up period was compared to evaluate rehabilitation and economic value. The results showed that the experimental group had lower Positive and Negative Syndrome Scale (PANSS), higher efficacy and lower relapse rates after treatment; both groups had improved quality of life and cognitive function-related indicators and the experimental group was more significant; the experimental group had higher Wisconsin Card Sorting Test (WCST) scores and better economic benefits; there were no serious adverse events in both groups. In summary, rTMS combined with antipsychotic drugs has good efficacy and safety in the treatment of schizophrenia, can improve patients' quality of life and economic benefits and provide a better choice for clinical treatment.
Publication Details
Page(s) 1558-1566
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 38, Issue: 5, Year: 2025

Request the full text from PASTIC

Keywords
Safety, efficacy, Antipsychotics, Schizophrenia, repetitive transcranial magnetic stimulation
References
Bingqian L,Hao Y,Shanling J,Jinguo Z J .2024 .Brain mechanisms and intervention measures for cognitive impairment in schizophrenia. J. Psychiatry., 37(03) : 319-324.
Brandt SJ,Oral HY,Arellano- Bravo C HY .2021 .Repetitive transcranial magnetic stimulation as a therapeutic and probe in schizophrenia: An examining the role of neuroimaging and future directions. , 18(2) : 827-844.
Buechler R,Wotruba D,Michels L D .2020 .Cortical volume difference ences in subjects at risk for psychosis are driven by surface area. Schizophr Bull, 46(6) : 1511-1519.
Caicai S,Hailing J,Lili Z,Yunshu Z,Keqing L Z .2025 .Research progress on the correlation between cognitive function and sleep spindles in schizophrenia. J. Neurosci. Ment, 25(02) : 103-108.
Cui LB,Fu YF,Liu L YF .2021 .Baseline structural and functional magnetic resonance imaging predicts early detection and evaluation of early detection and evaluation of early detection.magnetic resonance imaging predicts early treatment response in schizophrenia with radiomics strateg. Eur. J. Neurosci., 53(6) : 1961-1975.
Goff DC .2021 .The pharmacologic treatment of schizophrenia. JAMA, 325(2) : 175-176.
Gong J,Cui LB,Xi YB .2020 .Predicting response to electrocon- vulsive therapy combined with antipsychotic therapy.vulsive therapy combined with antipsychotics in schizophrenia using multi- parametric magnetic resonance imaging. Schizophr. Res., 216 : 262-271.
Gongquan L,Linjia C,Qingfang X C .2025 .Comparison of the clinical effects of lurasidone and olanzapine in the treatment of schizophrenia and their effects on patients' cognitive function. J. Clin. Res., 42(03) : 437-440.
Haiyu C,Jinjun L,Tianxiang Z,Ziwei T,Yue Q,Renrong W,Yeliang Y,Kai F,Wenjuan J,Yunxia J,Riyong Z,Jianzhong M,Jian L,Jing H L .2025 .Effects of sulforaphane on negative symptoms and cognitive impairments in chronic schizophrenia patients: A randomized double-blind trial. J. Psychiat. Res., 184 : 464-472.
Haiyuan W,Jianbo C,Ming Y,Yonghou Z Y .2024 .Research progress on the regulation of PI3K/Akt signaling pathway by traditional Chinese medicine in the prevention and treatment of schizophrenia. Chin. J. Exp. Tradit. Med, 30(08) : 280-289.
Kahl M,Wagner G,De La Cruz F G .2020 .Resilience and cortical thickness: a MRI study. Eur. Arch. Psychiatry. Clin. Neurosci., 270(5) : 533-539.
Mamidipalli Sai S,Anirudh B,Shobit G,Rajshekhar B,Sai Krishna T B .2024 .Predictors of response to rTMS in severe mental illnesses- schizophrenia and bipolar disorder. Curr. Behav, 11(3) : 146-163.
Mccutcheon RA,Reis Marques T,Howes OD .2020 .Schizophrenia- an o-verview. JAMA Psychiatry, 77(2) : 201-210.
Nobuyuki N,Spyridon S,Johannes Schneider T,Lasse B,Jinyoung P,Orestis E,Josef P,John MD,Hiroyoshi T,Stefan L .2025 .The trajectory of sedative adverse events caused by antipsychotics: A meta-analysis of individual participant data from randomised, placebocontrolled, clinical trials in acute phase schizophrenia. Lancet Psychiat, 12(4) : 266-275.
Songping Z,Jiangjiang C,Xin Z C .2025 .Comparison of the efficacy and safety of clozapine and aripiprazole in the treatment of schizophrenia. Med, 22(08) : 114-117.
Suzhen Y,Bailing W,Heling S,Meihong X,Fengchun W .2025 .Association between white blood cell counts and the efficacy on cognitive function after rTMS intervention in schizophrenia. , 11(1) : 41.
Xingmei D,Zhongting Y,Deng Rui D,Chen Ying C,Huang Yuan H C .2024 .Costeffectiveness analysis of five drug regimens for the treatment of schizophrenia. Chin. J. New Drugs, 33(19) : 2067-2074.
Yang C,Tang J,Liu N J .2021 .The effects of antipsychotic treatment on the brain of patients with first- episode schizophrenia: A selective review of longitudinal MRI studies. Front Psychiatry, 12 : 593703.
Zhao SW,Xu X,Wang XY .2021 .Shaping the Transscale proper ties of schizophrenia via cerebral alterations on magnetic resonance imaging and single- nucleotide polymorphisms of coding and non-coding regions. Front Hum Neurosci., 15 : 720239.
Zhenjiang G .2025 .Effects of mindfulness-based stress reduction on young and middle-aged patients with schizophrenia. Chin. J. Urban Rural Enterp. Hyg., 40(04) : 68-70.
0

Citations

0

Downloads

101

Views